James B. Groce III, Pharm.D., CPP, is Professor, Department of Pharmacy Practice at Campbell University College of Pharmacy and Health Sciences. He also is Clinical Assistant Professor of Medicine at the University of North Carolina School of Medicine, and Clinical Pharmacy Specialist-Anticoagulation at the Moses H. Cone Memorial Hospital in Greensboro, North Carolina.
Throughout his career in pharmacy, Dr. Groce has been published and cited on important healthcare topics in numerous peer-reviewed medical and pharmacy journals as well as textbooks of pharmacy. He has served as principal investigator on a number of studies, including many that supported the concept of outpatient treatment of venous thromboembolism. His published research has also evaluated the pharmacoeconomics of using low molecular weight heparins for outpatient treatment of deep venous thrombosis (DVT) in a community hospital setting, various heparin weight-based dosing nomograms, and the utility of heparin level determinations and outcomes analysis. He served as site-principle investigator for the DiET study. On December 10, 2016, the US Food and Drug Administration (FDA) cleared STA® – Liatest® D-Di for the exclusion of the diagnosis of deep vein thrombosis (DVT) on data reported from the multi-national, DiET study. Currently he is the principle investigator for an assay evaluating the performance of a chromogenic assay for the measurement of direct oral Factor Xa inhibtors—the results of which are before the FDA being evaluated for clearance as the first FDA approved assay for this purpose.
Dr. Groce’s colleagues and the public have benefited from his unique expertise. He served as the only Pharmacist upon the Technical Advisory Panel of The Joint Commission/National Quality Forum for creation of core measures for prevention and treatment of venous thromboembolism which culminated in National Hospital Quality Measures for venous thromboembolism October 1, 2009 in the United States. All these activities have earned Dr. Groce national and global recognition for his contributions to this clinical area of interest and research.